AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2019
May 16, 2019
30786_dirs_2019-05-15_6d7f2d04-55eb-487e-bfca-ffac990a2a1f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-05-15
Reporting Person: Magni Giovanni (EVP, Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-15 | Bio-Rad A Common Stock | M | 3500 | $74.27 | Acquired | 15420 | Direct |
| 2019-05-15 | Bio-Rad A Common Stock | F | 1803 | $290.6279 | Disposed | 13617 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-15 | Non-Qualified Stock Option (right to buy) | $74.27 | M | 3500 | Disposed | 2019-06-10 | Bio-Rad A Common Stock (3500) | Direct |
Footnotes
F1: The option vested in five equal annual installments beginning on June 10, 2010.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13